glp 1 alcohol use GLP-1s tied to lower intake for adults with overweight, obesity Why Might GLP-1 Drugs Reduce

PMCID: PMC8017323

Abstract Recent studies show that systemic administration of a glucagon-like peptide-1 receptor (GLP-1R) agonist is sufficient to attenuate the reinstatement of cocaine-seeking behavior, an animal model of relapse

Real-world patient data shows that 6070% of users report some gas or belching in the initial phase, but fewer than 20% experience these symptoms beyond 4 weeks of continuous use

Learn how these cutting-edge medications help suppress appetite, enhance fat metabolism, and support sustainable weight management

When using GLP-1s for weight loss, behavior changes like replacing snacking with movement and choosing home cooked food over the drive-through play a big factor in determining long-term success

While research in humans is still in the early stages, these findings point to the possibility that GLP-1-based treatments could help reduce cravings and withdrawal symptoms in individuals attempting to quit smoking